medetomidine has been researched along with cyclic gmp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, H; Virag, L; Vulliemoz, Y | 1 |
| Virag, L; Vulliemoz, Y; Whittington, RA | 1 |
2 other study(ies) available for medetomidine and cyclic gmp
| Article | Year |
|---|---|
Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brain Chemistry; Clonidine; Cyclic GMP; Imidazoles; Male; Medetomidine; Mice; NG-Nitroarginine Methyl Ester | 1996 |
Interaction of the alpha-2 adrenergic- and opioid receptor with the cGMP system in the mouse cerebellum.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Analysis of Variance; Animals; Cerebellum; Cyclic GMP; Fentanyl; Imidazoles; Male; Medetomidine; Mice; Naloxone; Narcotic Antagonists; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Yohimbine | 1998 |